Come up with a name for your new list and we'll add to it:
Oncoceutics raised a round of funding on September 23, 2014. Investors include
Spring Mountain Capital.
Oncoceutics is a clinical-stage drug discovery and development company targeting the most potent suppressor pathways in human cancer. The first lead compound to result from this program is ONC201, a s…